As the RNA Showgrounds undergo major changes for the 2032 Olympics, many are questioning how the beloved EKKA will be ...

TransCode Therapeutics, Inc. (Nasdaq: RNAZ), ("TransCode" or the "Company"), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the closing ...

Three stadiums within a shock new multibillion-dollar sport and entertainment precinct will anchor Brisbane’s landmark 2032 ...

RNAi -- functions specifically to silence, or deactivate, genes. Among other applications, it promises to be groundbreaking ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

One of the surprises in Tuesday’s long-awaited Brisbane 2032 Olympic and Paralympic Games announcement is another outdoor arena not recommended in the review.

Christus St. Vincent has purchased 1.64 acres in Los Alamos for the development and construction of a new multi-specialty ...

The pathogen C. diff - the most common cause of health care-associated infectious diarrhea - can use a compound that kills ...

Yale scientists have discovered a promising way to trigger immune responses against certain tumors, using a lupus-related antibody that can slip, undetected, into "cold" tumors and flip on an immune ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...